Jane Street’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
WCA
PVM
VCM
NI
Jane Street's HCAT Position: Q1 2026 in Review
Jane Street reduced its Health Catalyst (HCAT) stake by 91% in Q1 2026, selling an estimated $507K and leaving 26,568 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11083.
Jane Street first reported a position in HCAT in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.68M in Q1 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.
- Jane Street held 26,568 shares of Health Catalyst worth $33.7K as of Q1 2026.
- Jane Street sold 269,476 Health Catalyst shares in Q1 2026, an estimated $507K.
- Health Catalyst made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11083 holding.
- Jane Street first reported a position in Health Catalyst in Q1 2021 and has held it in 18 quarters since.
- Jane Street's Health Catalyst position peaked at $1.68M in Q1 2022.
- 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.